]>
IRCT20150706023084N18 IRCT 2023-09-02 Islamic Azad University Empagliflozin in non alcoholic fatty liver Investigating the effect of empagliflozin on patients with non alcoholic fatty liver diseases 2023-08-11 anticipated 30 Complete https://irct.ir/trial/71250 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Health service research, Other design features: Investigating the effect of empagliflozin on diabetic patient with non alcoholic fatty liver. 1-2 Diabetic patient with non alcoholic fatty liver. Intervention group : The case group are 30 patient with diabetic and non alcoholic fatty liver with treatment by empagliflozin in 3 month and then investigating of the result of empagliflozin by fatty liver by resulting of the sonography of patient. Yes - There is a plan to make this available What will be shared: The age, gender and demographic information of the patients as well as the results of the sonography and the questionnaire containing the symptoms of the patients at the beginning, during and at the end of the treatment period by removing the individual characteristics of the patients can be shared. When: The release time of the documents and files is after the completion of the project and in the winter of 1402. To whom: Researchers working in academic and scientific institutions Conditions: By observing the ethical principles of concealment of information, documents and all the checks carried out on the information can be published. Where to obtain: mobinashieh123@gmail.com How to obtain: Sending request email Comments:
public Mobina shieh
No 99 , Yasman Alley , Yakhchal street , Gholhak , Dr . Shariati street
Tehran Iran (Islamic Republic of) 193956466 +98 21 6659 6099 mobinashieh123@gmail.com Islamic Azad University scientific Mobina shieh
No.99, Yakhckal street, DR Shariati Avenue
Tehran Iran (Islamic Republic of) 193956466 +98 21 6659 6099 mobinashieh123@gmail.com Islamic Azad University Iran (Islamic Republic of) Diabetic patient Fatty liver Empagliflozin no limit no limit Both Drug use for fatty liver K75.8 Other specified inflammatory liver diseases Treatment - Drugs Intervention group : The case group are 30 patient with diabetic and non alcoholic fatty liver with treatment by empagliflozin in 3 month and then investigating of the result of empagliflozin by fatty liver by resulting of the sonography of patient Different grades of fatty liver. Timepoint: Before the intervention and 30 days after it, the question paper and sonography and fibroscan analysis data will be evaluated. Method of measurement: Investigating of sonography(fibroscan). Investigating sonography related to the course of recovery during treatment. Timepoint: From the beginning of treatment for 3 month. Method of measurement: Examining the sonography of the patients. Islamic Azad University Approved 2023-04-18 Ethics committee of Islamic Azad University No.99, Yakhckal street, DR Shariati Avenue TEHRAN Tehran Iran (Islamic Republic of)